KENNAMETAL INC (KMT): what the price requires
At today's price, KENNAMETAL INC (KMT) is priced for +11.9% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/KMT
Headline
| Field | Value |
|---|---|
| Ticker | KMT |
| Company | KENNAMETAL INC |
| Current price | $33.54/sh |
| Composition | Metal Cutting 62% / Infrastructure 38% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 7.8% |
| Operating margin today | 10.1% |
| Margin compression implied | -2.3pp |
| Implied growth | 11.9% |
| Multiple paid | 14x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 10.2% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6pp.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.31σ |
| cohort percentile (of 225 peers) | 18 |
| sustained it ~5 years at this level | 51% |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.69x | 5 | expensive |
| Earnings | 1.72x | 4 | expensive |
| Relative | 0.54x | 5 | justifies |
| Growth | 1.18x | 3 | expensive |
Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.6%); the inversion above states its own rate.
Per-Model Detail (n=17)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $24.85 | 1.35x | yes | FCF base $0.1B, growth 8% (input: historical growth), terminal g 4.0%, WACC 7.6%, 6yr projection |
| DCF Exit Multiple | Growth | $34.92 | 0.96x | yes | Exit EV/EBITDA: 7.1x / 9.1x / 11.1x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $40.29 | 0.83x | yes | P/E 18x (static sector reference · 2026-04), scenarios: 15.0x / 18.0x / 21.0x (bear / base = reference held flat / bull), EV/EBITDA 12x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $19.05 | 1.76x | yes | BV/sh $17.42, ROE (TTM) 10.1%, ke 9.3% |
| Two-Stage Excess Return | Asset | $19.89 | 1.69x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $28.42 | 1.18x | yes | Rev $2.1B, growth 8% (input: historical growth; tapered), Terminal P/S: 1.0x / 1.2x / 1.4x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $61.95 | 0.54x | yes | EPS $1.77, growth 35% (input: historical EPS growth), PEG=0.54 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $19.89 | 1.69x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.20B × (1−23%) / WACC 7.6% → EPV (no growth) |
| Residual Income | Asset | $20.05 | 1.67x | yes | BV $17.42 + 5yr PV of (ROE (TTM) 10.1% − Kₑ 9.3%) × BV; BV grows 6.6%/yr |
| Graham Number | Asset | $26.34 | 1.27x | yes | √(22.5 × EPS $1.77 × BVPS $17.42) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $46.56 | 0.72x | yes | EBITDA $0.35B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | $3.27 | 10.26x | yes | FCF $73.1M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $0.01 | 3354.00x | yes | SBC-adj FCF $0.04B (FCF $0.07B − SBC $0.03B) capitalized at Kₑ (excluded from median) |
| Ben Graham Formula | Earnings | $57.11 | 0.59x | yes | EPS $1.77 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $7.42 | 4.52x | yes | BV $17.42 × (ROIC 3.2% / WACC 7.6%) |
| P/Sales Sector | Relative | $68.69 | 0.49x | yes | Revenue $2.14B × sector P/S 2.5x |
| PEG Fair Value | Relative | $66.38 | 0.51x | yes | EPS $1.77 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $19.14 | 1.75x | yes | EPS $1.77 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $490.5m |
| Net debt / NOPAT (after-tax) | 2.99x |
| Net debt / operating income (pre-tax) | 2.30x |
| Interest coverage | 8.6x |
| Share count CAGR (buyback) | -1.9% |
| Burning cash | no |
Bullet Takeaways
The earnings trajectory turned sharply higher: fiscal Q3 2026 sales rose 22% to $592.6 million, operating margin expanded to 13.4% from 9.1%, and adjusted EPS jumped 65% to $0.77, prompting a raised full-year outlook of $3.75 to $4.00 adjusted EPS.
Much of the surge traces to an unprecedented rise in tungsten pricing, which lifted revenue and margin but also caused operating cash flow to decline on inventory buildup. The tailwind is real, and it is double-edged.
At $36.32 the price embeds about 15% annual operating growth for five years, a pace only about 44% of comparable companies have sustained. That is a demanding bet for a cyclical industrial that posted a 5% organic sales decline as recently as fiscal 2025.
Bull Case
The story is in the direction of the numbers, and the direction just reversed hard to the upside. Kennametal makes the cutting tools and wear-resistant components that machine shops, energy firms, and earthmovers consume, a Metal Cutting business at 62% of sales and an Infrastructure business at 38%. After a soft stretch, fiscal Q3 2026 showed a clean inflection: sales rose 22% to $592.6 million, organic growth of 19%, with operating income climbing to $79.4 million and operating margin expanding to 13.4% from 9.1% a year earlier. Adjusted EPS jumped 65% to $0.77. Results beat the high end of the company's own outlook, and end-market momentum was broad, Earthworks up 43%, Energy up 28%, Aerospace and Defense up 23%.
That margin expansion is the most important line, because it shows operating leverage working. A tooling business has high fixed costs, so when volume returns, incremental margins are strong, and the jump from 9.1% to 13.4% in a single year is exactly that effect. Management responded by raising the full-year 2026 outlook to sales of $2.33 to $2.35 billion and adjusted EPS of $3.75 to $4.00, a meaningful step up. The company sells under established brands, Kennametal, WIDIA, and the WIDIA Hanita and GTD lines, through a direct sales force that solves customers' machining challenges with customized, productivity-focused solutions (FY2025 10-K, accession 0000055242-25-000068), the kind of application engineering that builds switching costs in the metal-cutting niche.
The capital story rounds out the case. Kennametal pays a dividend yielding north of 2%, has been shrinking its share count about 2% a year, and against peers like Timken, Helios, and Gates offers a focused, brand-led tooling franchise at a reasonable multiple. Timken's own filing shows the diversified industrial demand picture both companies serve, spanning aerospace, automotive, agriculture, rail, construction, metals and mining, with no single customer above 5% of sales (TKR FY2025 10-K, accession 0000098362-26-000012). For Kennametal, the breadth means the recovery is not hostage to one end market. If the upturn extends and margins hold near the new level, the earnings power justifies the price comfortably.
Bear Case
The bear case is about what the price is quietly counting on, and the most fragile assumption is that the recent surge is sustainable rather than borrowed from a commodity spike. At $36.32 (June 27, 2026) the price embeds operating growth of about 15.2% per year for five years, and only about 44% of comparable companies have sustained that pace over such a horizon. The problem is that a large part of the Q3 jump came from what management itself called an unprecedented rise in tungsten pricing. Tungsten is the key raw material in cutting tools, so when its price rises, Kennametal's revenue and reported margin rise with it, but that is a pass-through inflation, not unit growth. Strip out the tungsten effect and the underlying demand growth is far less than the headline 22%. The price is extrapolating a commodity tailwind as if it were a durable franchise improvement.
The cash flow already shows the catch. Year-to-date operating cash flow and free cash flow declined because of inventory buildup from rising tungsten costs. That is the tell: the same tungsten spike that flatters the income statement is tying up cash in inventory, so the quality of the earnings surge is lower than the EPS line suggests. When tungsten prices normalize, the revenue tailwind reverses, and the company is left with the inventory it bought high.
The deeper fragility is the cycle, and Kennametal's own recent history proves it cuts both ways. Just one year earlier, fiscal 2025 was an organic sales decline of 5%, with General Engineering down 6%, Transportation down 6%, and Energy down 2% (FY2025 10-K, accession 0000055242-25-000068). This is a deeply cyclical industrial whose end markets, manufacturing, energy, construction, swing with the broader economy. The bull case leans on the up-leg continuing; the bear case is that 15% sustained growth requires both the tungsten tailwind to persist and the industrial cycle to keep climbing, two narrative-dependent assumptions stacked on top of each other. Net debt near $490 million, about 2.4x operating income, and thin trailing free cash flow leave little cushion if the cycle turns. Pay 15x for 15% growth and you are underwriting a peak that has a history of not lasting.
Valuation
The valuation reflects a cyclical industrial caught at an up-cycle inflection. At $36.32 the reverse-DCF reads the price as embedding operating growth of about 15.2% per year for five years, computed at a 10.3% cost of capital. That is a demanding assumption, near what the company has delivered in the recent surge but well above its through-the-cycle pace, and the engine notes only about 44% of comparable fast-growers sustained it. The method families split as you would expect for a name where current earnings are cyclically elevated by both volume and tungsten pricing.
The relative and growth frames straddle the price: relative valuation near $40, the DCF exit multiple near $37, discounted future market cap near $31, and the PEG and Peter Lynch methods far higher on strong recent EPS growth. The asset and earnings-power frames land well below, simple excess return near $19, earnings power value near $20 on a normalized five-year EBIT, residual income near $20, because the normalized through-the-cycle earnings are much lower than the current run-rate. The FCF-based methods collapse to near zero because free cash flow is depressed by the tungsten-driven inventory build, an artifact of the current moment rather than a steady-state read.
The honest synthesis is that the price is reasonable if you believe the current margin and revenue level holds, and rich if you mark the company to its through-the-cycle earnings. The asset methods near $20 are the conservative floor that assumes normalization; the relative methods near $40 assume the up-cycle persists. With net debt about 2.4x operating income and free cash flow temporarily impaired, the margin for error is thin if either the tungsten tailwind or the industrial cycle reverses.
Catalysts
Fiscal Q3 2026 (reported spring 2026) was a strong beat: sales rose 22% to $592.6 million, with organic growth of 19%, operating margin expanding to 13.4% from 9.1%, and adjusted EPS up 65% to $0.77, above the high end of guidance. End-market strength was led by Earthworks up 43%, Energy up 28%, and Aerospace and Defense up 23%. The company raised its full-year 2026 outlook to sales of $2.33 to $2.35 billion and adjusted EPS of $3.75 to $4.00. The next prints test whether the momentum holds as comparisons get harder.
The tungsten-price dynamic is the swing factor in both directions. Rising tungsten lifted revenue and margin but pressured free cash flow through inventory buildup, so watch the trajectory of tungsten costs, the gross-margin trend, and whether operating cash flow recovers as inventory normalizes. A tungsten reversal would unwind part of the revenue and margin tailwind.
The cyclical end markets are the macro tell. Demand from manufacturing, energy, construction, and aerospace drives the volume side of the story, and Kennametal's history of swinging from a 5% organic decline in fiscal 2025 to a 19% organic gain shows how fast the cycle moves. Track industrial production trends, the dividend, and continued buybacks against net debt near $490 million over the next 90 days.
Sources: PRNewswire (KMT Q3 FY2026 results), StockTitan (Q3 2026 8-K), Barchart, Alpha Spread, The Globe and Mail, AOL (Q3 2026 transcript).
Peer Cohorts (Per Segment, With Filing Citations)
Metal Cutting (reported)
- LECO (LINCOLN ELECTRIC HOLDINGS INC)
- (no filing in the citation store)
- KAI (KADANT INC)
- (no filing in the citation store)
- DCI (DONALDSON COMPANY, INC.)
- (no filing in the citation store)
- MLI (MUELLER INDUSTRIES INC)
- (no filing in the citation store)
Infrastructure (reported)
- ESAB (ESAB Corporation)
- (no filing in the citation store)
- MTRN (MATERION CORPORATION)
- (no filing in the citation store)
- CRS (CARPENTER TECHNOLOGY CORPORATION)
- (no filing in the citation store)
- GTES (Gates Industrial Corporation plc)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.